Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Midatech Pharma ADR (NQ: MTP ) N/A UNCHANGED Last Price Updated: 3:59 PM EDT, Mar 24, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Midatech Pharma ADR < Previous 1 2 Next > Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease March 27, 2023 Via ACCESSWIRE Midatech Pharma PLC Announces Results of General Meeting March 24, 2023 Via ACCESSWIRE Midatech Pharma PLC Announces Further re: Notice of General Meeting March 10, 2023 Via ACCESSWIRE Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting March 08, 2023 Via ACCESSWIRE Midatech Pharma PLC Announces Closing of $6.0m Private Placement & Broker Change February 15, 2023 Via ACCESSWIRE Midatech Pharma PLC Announces Private Placement Raising US $6.0 million February 09, 2023 Via ACCESSWIRE Midatech Pharma PLC Announces Result of General Meeting January 23, 2023 Via ACCESSWIRE Midatech Pharma PLC Announces Planned Dose Escalation in MTX-110 Phase 1 Study January 12, 2023 Via ACCESSWIRE Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting January 06, 2023 Via ACCESSWIRE Midatech Pharma PLC - First Patient Enrolled in Phase 1 Study of MTX-110 November 14, 2022 Via ACCESSWIRE Midatech Pharma PLC Announces Receipt of NASDAQ Notice February 03, 2023 Via ACCESSWIRE Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders January 11, 2023 From Bioasis Technologies Inc. Via GlobeNewswire Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc December 19, 2022 From Bioasis Technologies Inc. Via GlobeNewswire Midatech Pharma PLC Announces Closing of Offering, Revised Terms, AIM & Webinar December 19, 2022 Via ACCESSWIRE Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc December 13, 2022 US$10M Registered Direct Offering and PIPE to Strengthen Balance Sheet of Combined Company From Bioasis Technologies Inc. Via GlobeNewswire Midatech Pharma PLC Announces Proposed Acquisition of Bioasis Technologies Inc December 13, 2022 Via ACCESSWIRE Midatech Pharma PLC Announces Receipt of NASDAQ Notification October 18, 2022 Via ACCESSWIRE Midatech Pharma PLC Announces ADR Ratio Change September 14, 2022 Via ACCESSWIRE Midatech Pharma PLC Announces Interim Results for the Six Months to 30 June 2022 September 14, 2022 Via ACCESSWIRE Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma June 21, 2022 Orphan Designation Granted by EMA to MTX110 Development for the Treatment of Glioma From Midatech Pharma PLC Via AccessWire Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman June 10, 2022 ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines,... From Midatech Pharma PLC Via AccessWire Topics Retirement Exposures Pension Midatech Pharma PLC - MTX110 Study to be Presented at ISPNO 2022 June 10, 2022 ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines,... From Midatech Pharma PLC Via AccessWire Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development June 01, 2022 Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent Glioblastoma From Midatech Pharma PLC Via AccessWire Exposures Product Safety Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM May 24, 2022 ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 24, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of... From Midatech Pharma PLC Via AccessWire Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021 April 26, 2022 ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines,... From Midatech Pharma PLC Via AccessWire Midatech Pharma PLC Announces Receipt of NASDAQ Notice April 14, 2022 ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of... From Midatech Pharma PLC Via AccessWire Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule March 09, 2022 ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is... From Midatech Pharma PLC Via AccessWire Midatech Pharma PLC Announces Appointment of Nominated and Financial Adviser March 08, 2022 ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine, is... From Midatech Pharma PLC Via AccessWire Midatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effective December 13, 2021 Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON, OXFORDSHIRE / ACCESSWIRE / December 13, 2021 / Midatech Pharma PLC... From Midatech Pharma PLC Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Midatech Pharma PLC Announces Notice of Interim Results September 06, 2021 ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of... From Midatech Pharma PLC Via AccessWire Topics Intellectual Property Exposures Intellectual Property < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.